V. Paradis, S. Zalinski, E. Chelbi, N. Guedj, F. Degos et al., Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysis, Hepatology, vol.11, issue.3, pp.49-851, 2009.
DOI : 10.1002/hep.22734

K. G. Alberti, R. H. Eckel, S. M. Grundy, P. Z. Zimmet, J. I. Cleeman et al., International Diabetes Federation Task Force on, and International Association for the Study ofHarmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute, 2009.

E. S. Ford, Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S," Diabetes care, pp.2745-2749, 2005.

B. Balkau, M. Vernay, L. Mhamdi, M. Novak, D. Arondel et al., The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study, Diabetes & Metabolism, vol.29, issue.5, pp.29-526, 2003.
DOI : 10.1016/S1262-3636(07)70067-8

G. Bedogni, L. Miglioli, F. Masutti, C. Tiribelli, G. Marchesini et al., Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study, Hepatology, vol.123, issue.1, pp.44-52, 2005.
DOI : 10.1002/hep.20734

V. Ratziu, S. Bellentani, H. Cortez-pinto, C. Day, and G. Marchesini, A position statement on NAFLD/NASH based on the EASL 2009 special conference, A position statement on NAFLD/NASH based on the EASL 2009 special conference, pp.372-384, 2010.
DOI : 10.1016/j.jhep.2010.04.008

P. Angulo, Nonalcoholic Fatty Liver Disease, New England Journal of Medicine, vol.346, issue.16, pp.1221-1231, 2002.
DOI : 10.1056/NEJMra011775

M. Machado, P. Marques-vidal, C. , and H. , Hepatic histology in obese patients undergoing bariatric surgery, Journal of Hepatology, vol.45, issue.4, pp.600-606, 2006.
DOI : 10.1016/j.jhep.2006.06.013

I. Mazen, M. El-gammal, M. Abdel-hamid, and K. Amr, A novel homozygous missense mutation of the leptin gene (N103K) in an obese Egyptian patient, Molecular Genetics and Metabolism, vol.97, issue.4, pp.305-308, 2009.
DOI : 10.1016/j.ymgme.2009.04.002

C. G. Bell, D. Meyre, C. Samson, C. Boyle, C. Lecoeur et al., Association of Melanin-Concentrating Hormone Receptor 1 5' Polymorphism With Early-Onset Extreme Obesity, Diabetes, vol.54, issue.10, pp.54-3049, 2005.
DOI : 10.2337/diabetes.54.10.3049

URL : https://hal.archives-ouvertes.fr/hal-00174468

S. K. Panchal and L. Brown, Rodent Models for Metabolic Syndrome Research, Journal of Biomedicine and Biotechnology, vol.86, issue.2, p.351982, 2011.
DOI : 10.1096/fj.09-152678

S. F. Clarke, E. F. Murphy, K. Nilaweera, P. R. Ross, F. Shanahan et al., The gut microbiota and its relationship to diet and obesity, Gut Microbes, vol.19, issue.3, pp.186-202, 2012.
DOI : 10.1210/jc.2004-1830

C. J. Stein, C. , and G. A. , The Epidemic of Obesity, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.6, pp.2522-2525, 2004.
DOI : 10.1210/jc.2004-0288

R. P. Lopez and H. P. Hynes, Obesity, physical activity, and the urban environment: public health research needs Environmental health : a global access science source, p.25, 2006.

G. Cizza and K. I. Rother, Beyond fast food and slow motion: weighty contributors to the obesity epidemic, Journal of endocrinological investigation, vol.35, issue.2, pp.236-242, 2012.

C. P. Day, J. , and O. F. , Steatohepatitis: A tale of two ???hits????, Gastroenterology, vol.114, issue.4, pp.842-845, 1998.
DOI : 10.1016/S0016-5085(98)70599-2

J. K. Dowman, J. W. Tomlinson, and P. N. Newsome, Pathogenesis of non-alcoholic fatty liver disease, QJM, vol.103, issue.2, pp.71-83, 2010.
DOI : 10.1093/qjmed/hcp158

A. E. Feldstein, N. W. Werneburg, A. Canbay, M. E. Guicciardi, S. F. Bronk et al., O0040 FREE FATTY ACIDS PROMOTE HEPATIC LIPOTOXICITY BY STIMULATING TNF-ALPHA EXPRESSION VIA A LYSOSOMAL PATHWAY, Journal of Pediatric Gastroenterology and Nutrition, vol.39, issue.Supplement 1, pp.185-194, 2004.
DOI : 10.1097/00005176-200406001-00042

H. Tilg and A. R. Moschen, Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis, Hepatology, vol.11, issue.5, pp.1836-1846, 2010.
DOI : 10.1002/hep.24001

N. Alkhouri, C. Carter-kent, and A. E. Feldstein, Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications, Expert Review of Gastroenterology & Hepatology, vol.5, issue.2, pp.201-212, 2011.
DOI : 10.1586/egh.11.6

D. E. Kleiner, E. M. Brunt, M. Van-natta, C. Behling, M. J. Contos et al., Design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatology, vol.38, issue.6, pp.41-1313, 2005.
DOI : 10.1002/hep.20701

E. M. Brunt, Grading and staging the histopathological lesions of chronic hepatitis: The Knodell histology activity index and beyond, Hepatology, vol.22, issue.1, pp.241-246, 2000.
DOI : 10.1002/hep.510310136

P. Bedossa, C. Poitou, N. Veyrie, J. L. Bouillot, A. Basdevant et al., Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients, Hepatology, vol.100, issue.5, pp.56-1751, 2012.
DOI : 10.1002/hep.25889

M. Obika and H. Noguchi, Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease, Experimental Diabetes Research, vol.11, issue.6, p.145754, 2012.
DOI : 10.1381/0960892053723268

J. Chen, J. A. Talwalkar, M. Yin, K. J. Glaser, S. O. Sanderson et al., Early Detection of Nonalcoholic Steatohepatitis in Patients with Nonalcoholic Fatty Liver Disease by Using MR Elastography, Radiology, vol.259, issue.3, pp.749-756, 2011.
DOI : 10.1148/radiol.11101942

M. V. Machado, C. , and H. , Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal, Journal of Hepatology, vol.58, issue.5, pp.1007-1019, 2013.
DOI : 10.1016/j.jhep.2012.11.021

L. A. Adams, S. Sanderson, K. D. Lindor, and P. Angulo, The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies, Journal of Hepatology, vol.42, issue.1, pp.132-138, 2005.
DOI : 10.1016/j.jhep.2004.09.012

P. Mofrad, M. J. Contos, M. Haque, C. Sargeant, R. A. Fisher et al., Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values, Hepatology, vol.340, issue.6, pp.37-1286, 2003.
DOI : 10.1053/jhep.2003.50229

P. Sorrentino, G. Tarantino, P. Conca, A. Perrella, M. L. Terracciano et al., Silent nonalcoholic fatty liver disease-a clinical-histological study, Journal of hepatology, issue.5, pp.41-751, 2004.

A. E. Feldstein, A. Wieckowska, A. R. Lopez, Y. C. Liu, N. N. Zein et al., Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study, Hepatology, vol.48, issue.4, pp.1072-1078, 2009.
DOI : 10.1002/hep.23050

V. J. Lavallard, S. Bonnafous, S. Patouraux, M. C. Saint-paul, D. Rousseau et al., Serum Markers of Hepatocyte Death and Apoptosis Are Non Invasive Biomarkers of Severe Fibrosis in Patients with Alcoholic Liver Disease, PLoS ONE, vol.43, issue.3, p.17599, 2011.
DOI : 10.1371/journal.pone.0017599.t006

M. Yoneda, H. Mawatari, K. Fujita, H. Iida, K. Yonemitsu et al., High-sensitivity Creactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH, Journal of gastroenterology, issue.7, pp.42-573, 2007.

R. Anty, S. Bekri, N. Luciani, M. C. Saint-paul, M. Dahman et al., The Inflammatory C-Reactive Protein Is Increased in Both Liver and Adipose Tissue in Severely Obese Patients Independently from Metabolic Syndrome, Type 2 Diabetes, and NASH, The American Journal of Gastroenterology, vol.33, issue.8, pp.1824-1833, 2006.
DOI : 10.1111/j.1572-0241.2006.00724.x

J. M. Hui, G. C. Farrell, J. G. Kench, G. , and J. , High sensitivity C-reactive protein values do not reliably predict the severity of histological changes in NAFLD, Hepatology, vol.100, issue.5, pp.1458-1459, 2004.
DOI : 10.1002/hep.20223

E. Zimmermann, R. Anty, J. Tordjman, A. Verrijken, P. Gual et al., C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients, Journal of Hepatology, vol.55, issue.3, pp.660-665, 2011.
DOI : 10.1016/j.jhep.2010.12.017

M. Buratti, I. B. Amor, A. Staccini-myx, M. C. Saint-paul, F. Berthier et al., A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients, Alimentary pharmacology & therapeutics, vol.32, pp.11-12, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00583896

T. Poynard, V. Ratziu, F. Charlotte, D. Messous, M. Munteanu et al., Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease, BMC Gastroenterology, vol.128, issue.1, p.34, 2006.
DOI : 10.1053/j.gastro.2005.02.056

P. Angulo, J. C. Keach, K. P. Batts, and K. D. Lindor, Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis, Hepatology, vol.93, issue.6, pp.1356-1362, 1999.
DOI : 10.1002/hep.510300604

M. Yoneda, H. Mawatari, K. Fujita, K. Yonemitsu, S. Kato et al., Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage, Journal of Gastroenterology, vol.19, issue.Suppl 3, pp.375-381, 2007.
DOI : 10.1007/s00535-007-2014-3

P. Veillon, Y. Gallois, V. Moal, I. Fouchard-hubert, I. Charles et al., Assessment of new hyaluronic acid assays and their impact on FibroMeter scores, Clinica Chimica Acta, vol.412, issue.3-4, pp.3-4, 2011.
DOI : 10.1016/j.cca.2010.11.009

URL : https://hal.archives-ouvertes.fr/hal-01390672

P. Angulo, J. M. Hui, G. Marchesini, E. Bugianesi, J. George et al., The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD, Hepatology, vol.41, issue.4, pp.846-854, 2007.
DOI : 10.1002/hep.21496

P. Cales, J. Boursier, V. De-ledinghen, P. Halfon, Y. Bacq et al., Evaluation and improvement of a reliable diagnosis of cirrhosis by blood tests, Gastroenterologie clinique et biologique, pp.32-1050, 2008.
DOI : 10.1016/j.gcb.2008.09.017

P. Cales, F. Oberti, S. Michalak, I. Hubert-fouchard, M. C. Rousselet et al., A novel panel of blood markers to assess the degree of liver fibrosis, Hepatology, vol.39, issue.6, pp.42-1373, 2005.
DOI : 10.1002/hep.20935

P. Cales, J. Boursier, F. Oberti, I. Hubert, Y. Gallois et al., FibroMeters: a family of blood tests for liver fibrosis, Gastroenterologie clinique et biologique, pp.32-40, 2008.
DOI : 10.1016/S0399-8320(08)73992-7

G. L. Wong, Transient elastography: Kill two birds with one stone?, World Journal of Hepatology, vol.5, issue.5, pp.264-274, 2013.
DOI : 10.4254/wjh.v5.i5.264

V. W. Wong, J. Vergniol, G. L. Wong, J. Foucher, H. L. Chan et al., Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease, Hepatology, vol.50, issue.Suppl 1, pp.51-454, 2010.
DOI : 10.1002/hep.23312

S. Bota, H. Herkner, I. Sporea, P. Salzl, R. Sirli et al., Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis, Liver international : official journal of the International Association for the Study of the Liver, 2013.
DOI : 10.1111/liv.12240

S. Hafeez, A. , and M. H. , Bariatric Surgery as Potential Treatment for Nonalcoholic Fatty Liver Disease: A Future Treatment by Choice or by Chance?, Journal of Obesity, vol.222, issue.3, p.839275, 2013.
DOI : 10.1172/JCI30076

L. B. Van-wagner and M. E. Rinella, The role of insulin-sensitizing agents in the treatment of nonalcoholic steatohepatitis, Therapeutic advances in gastroenterology, pp.249-263, 2011.
DOI : 10.1172/JCI13505

A. J. Sanyal, N. Chalasani, K. V. Kowdley, A. Mccullough, A. M. Diehl et al., Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis, New England Journal of Medicine, vol.362, issue.18, pp.362-1675, 2010.
DOI : 10.1056/NEJMoa0907929

V. Ratziu, F. Charlotte, C. Bernhardt, P. Giral, M. Halbron et al., Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial, Hepatology, vol.357, issue.2, pp.51-445, 2010.
DOI : 10.1002/hep.23270

G. Musso, R. Gambino, M. Cassader, and G. Pagano, A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease, Hepatology, vol.51, issue.Supplement DDW, pp.79-104, 2010.
DOI : 10.1002/hep.23623

K. D. Lindor, K. V. Kowdley, E. J. Heathcote, M. E. Harrison, R. Jorgensen et al., Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial, Hepatology, vol.20, issue.3, pp.770-778, 2004.
DOI : 10.1002/hep.20092

V. Primeau, L. Coderre, A. D. Karelis, M. Brochu, M. E. Lavoie et al., Characterizing the profile of obese patients who are metabolically healthy, International Journal of Obesity, vol.13, issue.7, pp.35-971, 2011.
DOI : 10.1038/ijo.2010.216

T. Mclaughlin, C. Lamendola, A. Liu, and F. Abbasi, Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity, The Journal of clinical endocrinology and metabolism, issue.11, pp.96-1756, 2011.

R. P. Wildman, P. Muntner, K. Reynolds, A. P. Mcginn, S. Rajpathak et al., The Obese Without Cardiometabolic Risk Factor Clustering and the Normal Weight With Cardiometabolic Risk Factor Clustering, Archives of Internal Medicine, vol.168, issue.15, pp.168-1617, 1999.
DOI : 10.1001/archinte.168.15.1617

P. Patel and N. Abate, Body Fat Distribution and Insulin Resistance, Nutrients, vol.5, issue.6, pp.2019-2027, 2013.
DOI : 10.3390/nu5062019

H. C. Hong, J. S. Lee, H. Y. Choi, S. J. Yang, H. J. Yoo et al., Liver enzymes and vitamin D levels in metabolically healthy but obese individuals: Korean National Health and Nutrition Examination Survey, Metabolism: clinical and experimental, 2013.
DOI : 10.1016/j.metabol.2013.04.002

V. Messier, A. D. Karelis, M. E. Robillard, P. Bellefeuille, M. Brochu et al., Metabolically healthy but obese individuals: relationship with hepatic enzymes, Metabolism, vol.59, issue.1, pp.20-24, 2010.
DOI : 10.1016/j.metabol.2009.06.020

D. Prati, E. Taioli, A. Zanella, E. Della-torre, S. Butelli et al., Updated Definitions of Healthy Ranges for Serum Alanine Aminotransferase Levels, Annals of Internal Medicine, vol.137, issue.1, pp.1-10, 2002.
DOI : 10.7326/0003-4819-137-1-200207020-00006

S. S. Kunde, A. J. Lazenby, R. H. Clements, and G. A. Abrams, Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women, Hepatology, vol.123, issue.3, pp.650-656, 2005.
DOI : 10.1002/hep.20818

R. Lomonaco, C. Ortiz-lopez, B. Orsak, A. Webb, J. Hardies et al., Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease, Hepatology, vol.143, issue.5, pp.55-1389, 2012.
DOI : 10.1002/hep.25539

D. L. Diab, L. Yerian, P. Schauer, S. R. Kashyap, R. Lopez et al., Cytokeratin 18 Fragment Levels as a Noninvasive Biomarker for Nonalcoholic Steatohepatitis in Bariatric Surgery Patients, Clinical Gastroenterology and Hepatology, vol.6, issue.11, pp.1249-1254, 2008.
DOI : 10.1016/j.cgh.2008.07.016

T. I. Tamimi, H. M. Elgouhari, N. Alkhouri, L. M. Yerian, M. P. Berk et al., An apoptosis panel for nonalcoholic steatohepatitis diagnosis, Journal of Hepatology, vol.54, issue.6, pp.1224-1229, 2011.
DOI : 10.1016/j.jhep.2010.08.023

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098936

Z. M. Younossi, M. Jarrar, C. Nugent, M. Randhawa, M. Afendy et al., A Novel Diagnostic Biomarker Panel for Obesity-related Nonalcoholic Steatohepatitis (NASH), Obesity Surgery, vol.22, issue.3, pp.18-1430, 2008.
DOI : 10.1007/s11695-008-9506-y

A. Tran and P. Gual, Non-alcoholic steatohepatitis in morbidly obese patients Clinics and research in hepatology and gastroenterology, pp.17-29, 2013.

K. Yamaguchi, L. Yang, S. Mccall, J. Huang, X. X. Yu et al., Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis, Hepatology, vol.272, issue.6, pp.45-1366, 2007.
DOI : 10.1002/hep.21655

Q. M. Anstee, A. K. Daly, and C. P. Day, Genetic modifiers of nonalcoholic fatty liver disease progression, Biochimica et biophysica acta, issue.11, pp.1812-1557, 2011.

S. Romeo, J. Kozlitina, C. Xing, A. Pertsemlidis, D. Cox et al., Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease, Nature Genetics, vol.164, issue.12, pp.40-1461, 2008.
DOI : 10.1038/ng1984

E. K. Speliotes, L. M. Yerges-armstrong, J. Wu, R. Hernaez, L. J. Kim et al., Genome-Wide Association Analysis Identifies Variants Associated with Nonalcoholic Fatty Liver Disease That Have Distinct Effects on Metabolic Traits, PLoS Genetics, vol.81, issue.3, p.1001324, 2011.
DOI : 10.1371/journal.pgen.1001324.s010

Y. Rotman, C. Koh, J. M. Zmuda, D. E. Kleiner, T. J. Liang et al., The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease, Hepatology, vol.29, issue.3, pp.894-903, 2010.
DOI : 10.1002/hep.23759

M. Hoekstra, Z. Li, J. K. Kruijt, M. Van-eck, T. J. Van-berkel et al., The expression level of non-alcoholic fatty liver disease-related gene PNPLA3 in hepatocytes is highly influenced by hepatic lipid status, Journal of Hepatology, vol.52, issue.2, pp.244-251, 2010.
DOI : 10.1016/j.jhep.2009.11.004

J. B. Dixon, P. S. Bhathal, O. Brien, and P. E. , Nonalcoholic Fatty Liver Disease: Predictors of Nonalcoholic Steatohepatitis and Liver Fibrosis in the Severely Obese, Gastroenterology, vol.121, issue.1, pp.91-100, 2001.
DOI : 10.1053/gast.2001.25540

E. M. Brunt, D. E. Kleiner, L. A. Wilson, P. Belt, B. A. Neuschwander-tetri et al., Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings, Hepatology, vol.44, issue.3, pp.810-820, 2011.
DOI : 10.1002/hep.24127

G. Lassailly, R. Caiazzo, A. Hollebecque, D. Buob, E. Leteurtre et al., Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity, European Journal of Gastroenterology & Hepatology, vol.23, issue.6, pp.499-506, 2011.
DOI : 10.1097/MEG.0b013e3283464111